BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 9, 2026
Breaking News: Best of BioWorld Science: Q1
Breaking News: Best of BioWorld: Q1
Breaking News: Best of BioWorld Science: Q1
Home
»
Topics
» BioWorld Science, Nephrology
BioWorld Science, Nephrology
RSS
Synaptic, Merck extend BPH collaboration
Nov. 8, 1996
CV Therapeutics reports novel adenosine antagonist
Nov. 8, 1996
Potential use of phytopharmaceutical compounds for BPH
Nov. 1, 1996
Muscarinic antagonists from Yamanouchi
Oct. 25, 1996
New alternative available for BPH
Oct. 18, 1996
Merck persists in the search for BPH therapeutics
Oct. 18, 1996
Renal-urologic drugs in development at Yamanouchi
Oct. 11, 1996
Three renal-urologic drugs reported in the Fujisawa product pipeline
Oct. 11, 1996
New BPH therapy cleared by the FDA
Oct. 11, 1996
Further launches scheduled for tamsulosin
Oct. 11, 1996
Previous
1
2
…
317
318
319
320
321
322
323
324
325
…
328
329
Next